Cystathionine beta synthase deficiency induces catalase-mediated hydrogen peroxide detoxification in mice liver

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 7-8, 2008, Pages 482-488

  Hamelet, Julien ^a   Seltzer, Virginie ^a   Petit, Emile ^a   Noll, Christophe ^a   Andreau, Karine ^a   Delabar, Jean M ^a   Janel, Nathalie ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

Author keywords

Homocysteine; NADPH oxidase; Oxidative stress; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; NITRITE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTATHIONINE BETA SYNTHASE; HEME OXYGENASE 1; PRIMER DNA; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HETEROZYGOSITY; HOMOCYSTINURIA; HYPERHOMOCYSTEINEMIA; LIVER; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; DISEASE MODEL; GENETICS; HETEROZYGOTE; HUMAN; METABOLISM; MOUSE MUTANT; NUCLEOTIDE SEQUENCE;

MURINAE; MUS;

ANIMALS; BASE SEQUENCE; CATALASE; CYSTATHIONINE BETA-SYNTHASE; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEMALE; HEME OXYGENASE-1; HETEROZYGOTE; HOMOCYSTINURIA; HUMANS; HYDROGEN PEROXIDE; HYPERHOMOCYSTEINEMIA; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; NADPH OXIDASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 49649119223     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.05.003     Document Type: Article

References (61)

1. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 19 (1999) 217-246
2. Kang S.S., Wong P.W., and Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 12 (1992) 279-298
3. Gibson J.B., Carson N.A., and Neill D.W. Pathological findings in homocystinuria. J. Clin. Pathol. 17 (1964) 427-437
4. McCully K.S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56 (1969) 111-128
5. Lentz S.R. Mechanisms of thrombosis in hyperhomocysteinemia. Curr. Opin. Hematol. 5 (1998) 343-349
6. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338 (1998) 1042-1050
7. Eikelboom J.W., Lonn E., Genest Jr. J., Hankey G., and Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131 (1999) 363-375
8. Temple M.E., Luzier A.B., and Kazierad D.J. Homocysteine as a risk factor for atherosclerosis. Ann. Pharmacother. 34 (2000) 57-65
9. Lentz S.R. Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 3 (2005) 1646-1654
10. Upchurch Jr. G.R., Welch G.N., Fabian A.J., Freedman J.E., Johnson J.L., Keaney Jr. J.F., and Loscalzo J. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272 (1997) 17012-17017
11. Eberhardt R.T., Forgione M.A., Cap A., Leopold J.A., Rudd M.A., Trolliet M., Heydrick S., Stark R., Klings E.S., Moldovan N.I., Yaghoubi M., Goldschmidt-Clermont P.J., Farber H.W., Cohen R., and Loscalzo J. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 106 (2000) 483-491
12. Stead L.M., Brosnan M.E., and Brosnan J.T. Characterization of homocysteine metabolism in the rat liver. Biochem. J. 350 (2000) 685-692
13. García-Tevijano E.R., Berasain C., Rodríguez J.A., Corrales F.J., Arias R., Martín-Duce A., Caballería J., Mato J.M., and Avila M.A. Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension 38 (2001) 1217-1221
14. Werstuck G.H., Lentz S.R., Dayal S., Hossain G.S., Sood S.K., Shi Y.Y., Zhou J., Maeda N., Krisans S.K., Malinow M.R., and Austin R.C. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107 (2001) 1263-1273
15. Woo C.W., Siow Y.L., Pierce G.N., Choy P.C., Minuk G.Y., Mymin D., and K.O. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E1002-E1010
16. Namekata K., Enokido Y., Ishii I., Nagai Y., Harada T., and Kimura H. Abnormal lipid metabolism in cystathionine beta-synthase-deficient mice, an animal model for hyperhomocysteinemia. J. Biol. Chem. 279 (2004) 52961-52969
17. Mikael L.G., Genest Jr. J., and Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ. Res. 98 (2006) 564-571
18. Hamelet J., Demuth K., Delabar J.M., and Janel N. Hyperhomocysteinemia due to cystathionine beta synthase deficiency induces dysregulation of genes involved in hepatic lipid homeostasis in mice. J. Hepatol. 46 (2007) 151-159
19. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 (1986) 1370-1376
20. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest. 98 (1996) 5-7
21. Weiss N., Zhang Y.Y., Heydrick S., Bierl C., and Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 12503-12508
22. Munday R. Toxicity of thiols and disulphides: involvement of free-radical species. Free Radic. Biol. Med. 7 (1989) 659-673
23. Watanabe M., Osada J., Aratani Y., Kluckman K., Reddick R., Malinow M.R., and Maeda N. Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 92 (1995) 1585-1589
24. Chen Z., Karaplis A.C., Ackerman S.L., Pogribny I.P., Melnyk S., Lussier-Cacan S., Chen M.F., Pai A., John S.W., Smith R.S., Bottiglieri T., Bagley P., Selhub J., Rudnicki M.A., James S.J., and Rozen R. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 10 (2001) 433-443
25. Swanson D.A., Liu M.L., Baker P.J., Garrett L., Stitzel M., Wu J., Harris M., Banerjee R., Shane B., and Brody L.C. Targeted disruption of the methionine synthase gene in mice. Mol. Cell. Biol. 21 (2001) 1058-1065
26. Woo C.W., Prathapasinghe G.A., Siow Y.L., and K.O. Hyperhomocysteinemia induces liver injury in rat: protective effect of folic acid supplementation. Biochim. Biophys. Acta 1762 (2006) 656-665
27. Robin S., Courderot-Masuyer C., Nicod L., Jacqueson A., Richert L., and Berthelot A. Opposite effect of methionine-supplemented diet, a model of hyperhomocysteinemia, on plasma and liver antioxidant status in normotensive and spontaneously hypertensive rats. J. Nutr. Biochem. 15 (2004) 80-89
28. Dayal S., Brown K.L., Weydert C.J., Oberley L.W., Arning E., Bottiglieri T., Faraci F.M., and Lentz S.R. Deficiency of glutathione peroxidase-1 sensitizes hyperhomocysteinemic mice to endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1996-2002
29. Huang R.F., Hsu Y.C., Lin H.L., and Yang F.L. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J. Nutr. 131 (2001) 33-38
30. Chanson A., Sayd T., Rock E., Chambon C., Santé-Lhoutellier V., Potier de Courcy G., and Brachet P. Proteomic analysis reveals changes in the liver protein pattern of rats exposed to dietary folate deficiency. J. Nutr. 135 (2005) 2524-2529
31. Weiss N., Heydrick S., Zhang Y.Y., Bierl C., Cap A., and Loscalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 34-41
32. Robert K., Chassé J.F., Santiard-Baron D., Vayssettes C., Chabli A., Aupetit J., Maeda N., Kamoun P., London J., and Janel N. Altered gene expression in liver from a murine model of hyperhomocysteinemia. J. Biol. Chem. 278 (2003) 31504-31511
33. Fortin L.J., and Genest Jr. J. Measurement of homocyst(e)ine in the prediction of atherosclerosis. Clin. Biochem. 28 (1995) 155-162
34. Rozen S., and Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols: Methods in Molecular Biology (2000), Humana Press, Totowa 365-386
35. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29 (2001) e45
36. Iwai M., Chen R., Li Z., Shiuchi T., Suzuki J., Ide A., Tsuda M., Okumura M., Min L.J., Mogi M., and Horiuchi M. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation 112 (2005) 1636-1643
37. Kolbeck R.C., She Z.W., Callahan L.A., and Nosek T.M. Increased superoxide production during fatigue in the perfused rat diaphragm. Am. J. Respir. Crit. Care Med. 156 (1997) 140-145
38. Marzinzig M., Nussler A.K., Stadler J., Marzinzig E., Barthlen W., Nussler N.C., Beger H.G., Morris Jr. S.M., and Brückner U.B. Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1 (1997) 177-189
39. Romitelli F., Santini S.A., Chierici E., Pitocco D., Tavazzi B., Amorini A.M., Lazzarino G., and Di Stasio E. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 851 (2007) 257-267
40. Vanuffelen B.E., Van Der Zee J., De Koster B.M., Vansteveninck J., and Elferink J.G. Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration. Biochem. J. 330 (1998) 719-722
41. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
42. Carmagnol F., Sinet P.M., and Jerome H. Selenium-dependent and non-selenium-dependent glutathione peroxidases in human tissue extracts. Biochim. Biophys. Acta 759 (1983) 49-57
43. Carlberg I., and Mannervik B. Glutathione reductase. Methods Enzymol. 113 (1985) 484-490
44. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
45. Bauer M., and Bauer I. Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress. Antioxid. Redox. Signal. 4 (2002) 749-758
46. Hon W.M., Lee K.H., and Khoo H.E. Nitric oxide in liver diseases: friend, foe, or just passerby?. Ann. N. Y. Acad. Sci. 962 (2002) 275-295
47. Nishio E., and Watanabe Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: a possible role for hydrogen peroxide. Br. J. Pharmacol. 122 (1997) 269-274
48. Symons J.D., Zaid U.B., Athanassious C.N., Mullick A.E., Lentz S.R., and Rutledge J.C. Influence of folate on arterial permeability and stiffness in the absence or presence of hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 814-818
49. Troen A.M., Lutgens E., Smith D.E., Rosenberg I.H., and Selhub J. The atherogenic effect of excess methionine intake. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15089-15094
50. Vitvitsky V., Dayal S., Stabler S., Zhou Y., Wang H., Lentz S.R., and Banerjee R. Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004) R39-46
51. Dayal S., Wilson K.M., Leo L., Arning E., Bottiglieri T., and Lentz S.R. Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood 108 (2006) 2237-2243
52. Datla S.R., Dusting G.J., Mori T.A., Taylor C.J., Croft K.D., and Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase-derived oxidative stress. Hypertension 50 (2007) 636-642
53. Robert K., Nehmé J., Bourdon E., Pivert G., Friguet B., Delcayre C., Delabar J.M., and Janel N. Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis and steatosis in mice liver. Gastroenterology 128 (2005) 1405-1415
54. Likogianni V., Janel N., Ledru A., Beaune P., Paul J.L., and Demuth K. Thiol compounds metabolism in mice, rats and humans: comparative study and potential explanation of rodents protection against vascular diseases. Clin. Chim. Acta 372 (2006) 140-146
55. Gaetani G.F., Ferraris A.M., Rolfo M., Mangerini R., Arena S., and Kirkman H.N. Predominant role of catalase in the disposal of hydrogen peroxide within human erythrocytes. Blood 87 (1996) 1595-1599
56. Yano S., and Yano N. Regulation of catalase enzyme activity by cell signaling molecules. Mol. Cell. Biochem. 240 (2002) 119-130
57. Robert K., Pagès C., Ledru A., Delabar J., Caboche J., and Janel N. Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 133 (2005) 925-935
58. Woo C.W., Siow Y.L., and K.O. Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1043-1050
59. Sindhu R.K., Ehdaie A., Farmand F., Dhaliwal K.K., Nguyen T., Zhan C.D., Roberts C.K., and Vaziri N.D. Expression of catalase and glutathione peroxidase in renal insufficiency. Biochim. Biophys. Acta 1743 (2005) 86-92
60. BobillierChaumont S., Maupoil V., and Berthelot A. Metallothionein induction in the liver, kidney, heart and aorta of cadmium and isoproterenol treated rats. J. Appl. Toxicol. 26 (2006) 47-55
61. Damotte D., Robert K., Hamelet J., Janel N., and Chassé J.F. Homocysteine is not detected in normal human vessel walls. Atherosclerosis 179 (2005) 211-212